ArticleTrials2022

Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.

Matthew Tunbridge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.